Inhibrx Biosciences, Inc
Inhibrx Biosciences develops biologic therapeutics using protein engineering platforms.
SCHEDULE 13G/ANov 13Latest SEC filing
Nov 12Latest story
Inhibrx Biosciences develops biologic therapeutics using protein engineering platforms.
November 2026
September 2026
August 2026
July 2026